CStone Pharmaceuticals
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 2616.HK | 9966.HK | 688382.SS | SMZ1.F | 2171.HK | 1167.HK | |
|---|---|---|---|---|---|---|
| Market cap | 8.98B | 6.43B | 8.38B | 11.09B | 6.48B | 3.85B |
| P/E (TTM) | — | — | — | 31.2 | — | 6.6 |
| Forward P/E | 137.0 | -21.0 | -43.8 | — | 96.2 | -167.5 |
| Price/book | 5.9 | 3.3 | 6.6 | 2.6 | 5.0 | 2.4 |
| Dividend yield | — | — | — | 2.90% | — | — |
| 1-year change | −7.84% | −39.84% | −48.70% | −23.60% | −29.62% | −32.34% |
| Today | +4.16% | +1.68% | +4.33% | +1.45% | +3.36% | +3.58% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All 2616.HK news ›Kimia Therapeutics Advances Oncology Asset to Clinical Stage in Collaboration with CStone Pharmaceuticals
– Kimia advances novel drug candidate targeting pathways critical for tumor cell survival into Phase 1 in collaboration with CStone Pharmaceuticals – CStone will lead Phase 1 development in mainland China and Australia, while Kimia is…
CStone Pharmaceuticals Teams Up with California's Kimia to Target Solid Tumors; Shares Jump Nearly 4% Intraday
CStone Pharmaceuticals-B (02616.HK) saw its shares rise as much as nearly 4% intraday on the 4th, reflecting the company's clinical development collaboration with California-based biopharmaceutical company Kimia Therapeutics. The two…
CStone Pharmaceuticals Enters into Exclusive Commercialization Agreement with Arrotex Pharmaceuticals for Sugemalimab Across Australia and New Zealand
CStone Pharmaceuticals announced that it has entered into an exclusive commercialization agreement with Arrotex Pharmaceuticals Pty Ltd. for the commercialization of sugemalimab in Australia and New... CStone Pharmaceuticals announced that…
GF Securities Starts CStone Pharmaceuticals at Buy with HK$11.56 Price Target
... GF Securities Starts CStone Pharmaceuticals at Buy with HK$11.56 Price Target Published on 10/09/2026 at 06:45 am EDT
CStone Pharmaceuticals Joins Stock Connect Southbound Trading
CStone Pharmaceuticals said its Hong Kong-listed shares have been added to the eligible securities list for southbound trading under Stock Connect, effective Sept. 7, according to a same-day Hong... CStone Pharmaceuticals Joins Stock…
Cstone Pharmaceuticals Provides Updates on Cs2009 and Pipeline 2.0 Clinical Trials and Product Portfolio
CStone Pharmaceuticals announced its 2026 interim results and recent business highlights. As of August 2026, updated data further confirmed the favorable safety profile of CS2009 and demonstrated...
CStone Pharmaceuticals Drug Receives Ethics Approval in Australia
CStone Pharmaceuticals received ethics approval to begin clinical trials of its core candidate CS5007 in Australia, according to a Friday filing with the Hong Kong bourse. The firm plans to enroll... CStone Pharmaceuticals Drug Receives…
CStone Pharmaceuticals: Relative Strength Chart - Stock Hong Kong S.E.
Compare CStone Pharmaceuticals with the company of your choice via a Relative Strength chart. Real-time 2616 price, Hong Kong S.E. stock exchange Relative Strength Chart CStone Pharmaceuticals All financial news and data tailored to…
Cstone Pharmaceuticals Announces Updated Clinical Data and Esmo 2026 Presentations for Cs2009 Trispecific Antibody
CStone Pharmaceuticals announced that the clinical research results of one of its core assets, CS2009 have been accepted for two Rapid Oral presentations at the European Society for Medical Oncology ... CStone Pharmaceuticals announced…
CStone Pharmaceuticals' Application for Tumor Drug Gets China Nod in 23 Days
CStone Pharmaceuticals' investigational new drug application for CS5007 was rapidly approved by China's National Medical Products Administration in 23 days. The global multicenter phase I study of... CStone Pharmaceuticals' Application for…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com6
- biospace.com1
- finance.biggo.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 8 articles, not a forecast.